-transparent.png){kind=logo}
Three patients initially diagnosed with Hodgkin's disease developed non-Hodgkin's lymphoma 1.5, 7, and 16 years later, respectively. Combined modality therapy had been employed in one patient; the other two had received combination chemotherapy. All three of the second neoplasms were morphologically characterized as peripheral T-cell lymphomas. Cell surface marker studies performed on two of these tumors confirmed their T-cell origin. Second lymphoproliferative malignancies are an increasingly recognized complication in patients with Hodgkin's disease. Further immunologic phenotyping is needed to more conclusively define the origin and frequency of occurrence of these tumors.
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
January 2015,
Case reports in oncological medicine,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
January 1995,
Archives of pathology & laboratory medicine,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
May 1987,
Orvosi hetilap,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
April 1999,
Leukemia & lymphoma,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
April 1997,
Archives of pathology & laboratory medicine,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
May 1992,
Cancer,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
February 1994,
Sangre,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
August 1995,
European journal of haematology,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
November 1992,
Seminars in diagnostic pathology,
G T Gowitt, and
W C Chan, and
R K Brynes, and
L T Heffner
October 1981,
Cancer,
